Found 18 results
Author Keyword Title Type [ Year(Asc)]
Filters: Keyword is Lipoproteins, LDL  [Clear All Filters]
2017
Bobe G, Cobb TJ, Leonard SW, Aponso S, Bahro CB, Koley D, Mah E, Bruno RS, Traber MG.  2017.  Increased static and decreased capacity oxidation-reduction potentials in plasma are predictive of metabolic syndrome.. Redox Biol. 12:121-128.
2015
Mah E, Sapper TN, Chitchumroonchokchai C, Failla ML, Schill KE, Clinton SK, Bobe G, Traber MG, Bruno RS.  2015.  α-Tocopherol bioavailability is lower in adults with metabolic syndrome regardless of dairy fat co-ingestion: a randomized, double-blind, crossover trial.. Am J Clin Nutr. 102(5):1070-80.
2013
Mah E, Pei R, Guo Y, Ballard KD, Barker T, Rogers VE, Parker BA, Taylor AW, Traber MG, Volek JS et al..  2013.  γ-Tocopherol-rich supplementation additively improves vascular endothelial function during smoking cessation.. Free Radic Biol Med. 65:1291-1299.
2002
Carr AC, Frei B.  2002.  Human neutrophils oxidize low-density lipoprotein by a hypochlorous acid-dependent mechanism: the role of vitamin C.. Biol Chem. 383(3-4):627-36.
Zhu B-Z, Carr AC, Frei B.  2002.  Pyrrolidine dithiocarbamate is a potent antioxidant against hypochlorous acid-induced protein damage.. FEBS Lett. 532(1-2):80-4.
2001
Carr AC, Decker EA, Park Y, Frei B.  2001.  Comparison of low-density lipoprotein modification by myeloperoxidase-derived hypochlorous and hypobromous acids.. Free Radic Biol Med. 31(1):62-72.
Carr AC.  2001.  Hypochlorous acid-modified low-density lipoprotein inactivates the lysosomal protease cathepsin B: protection by ascorbic and lipoic acids.. Redox Rep. 6(6):343-9.
McCall MR, Carr AC, Forte TM, Frei B.  2001.  Ldl modified by hypochlorous acid is a potent inhibitor of lecithin-cholesterol acyltransferase activity.. Arterioscler Thromb Vasc Biol. 21(6):1040-5.
Carr AC, Frei B.  2001.  The nitric oxide congener nitrite inhibits myeloperoxidase/H2O2/ Cl- -mediated modification of low density lipoprotein.. J Biol Chem. 276(3):1822-8.
Ivanov V, Carr AC, Frei B.  2001.  Red wine antioxidants bind to human lipoproteins and protect them from metal ion-dependent and -independent oxidation.. J Agric Food Chem. 49(9):4442-9.
2000
Miranda CL, Stevens JF, Ivanov V, McCall M, Frei B, Deinzer ML, Buhler DR.  2000.  Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro.. J Agric Food Chem. 48(9):3876-84.
Carr AC, Myzak MC, Stocker R, McCall MR, Frei B.  2000.  Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis.. FEBS Lett. 487(2):176-80.
Carr AC, McCall MR, Frei B.  2000.  Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection.. Arterioscler Thromb Vasc Biol. 20(7):1716-23.
Carr AC, Zhu BZ, Frei B.  2000.  Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E).. Circ Res. 87(5):349-54.
Carr AC, Tijerina T, Frei B.  2000.  Vitamin C protects against and reverses specific hypochlorous acid- and chloramine-dependent modifications of low-density lipoprotein.. Biochem J. 346 Pt 2:491-9.
1999
McCall MR, Frei B.  1999.  Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med. 26(7-8):1034-53.
Frei B.  1999.  On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction.. Proc Soc Exp Biol Med. 222(3):196-204.
1997
Roomi MW.  1997.  Association between hyperlipidemia and hepatic cytochrome P-450 in guinea pigs.. Res Commun Mol Pathol Pharmacol. 97(2):139-50.